Mallorie Gordon

A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors

Gary K. Schwartz, Stephanie Robertson, Angela Shen et al. · Journal of Clinical Oncology · 2009 · 95 citations

Raf Kinase Inhibitors, Pathology, Advanced Solid Tumors +17

Phase I and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies

Jakob Dupont, L. Schwartz, Jason A. Koutcher et al. · Journal of Clinical Oncology · 2004 · 56 citations

Surgical Oncology, Vegf Trap, Immunology +23

Phase I and pharmacokinetic study of VEGF Trap administered subcutaneously (sc) to patients (pts) with advanced solid malignancies

Jakob Dupont, Lawrence H. Schwartz, J.A. Koutcher et al. · Journal of Clinical Oncology · 2004 · 26 citations

Surgical Oncology, Vegf Trap, Immunology +23

“It’s Not JUST Skin Cancer”: Understanding Their Cancer Experience From Melanoma Survivor Narratives Shared Online

Smita C. Banerjee, Thomas A. D’Agostino, Mallorie Gordon et al. · Health Communication · 2016 · 25 citations · Full text

Nursing, Media Studies, Unique Ways +14

Patient perspectives on ipilimumab across the melanoma treatment trajectory

Elyse Shuk, Alexander N. Shoushtari, Jason J. Luke et al. · Supportive Care in Cancer · 2017 · 22 citations · Full text

Melanoma Treatment Trajectory, Medicine, Melanoma +5